The cell culture experiments, using 21 breast cancer cell lines had shown that sensitivity of breast cancer cell lines to AKT inhibitors AZD5363 and MK-2206 correlates with SGK1 mRNA levels. This evidence concerns the gene AKT1 and breast carcinoma.